Mariana Oncology is a fully integrated next generation radiopharmaceutical company that brings together experts in ligand discovery, radiochemistry, radiobiology and oncology translational and clinical research in order to build a pipeline across a range of solid tumor types. Our mission at Mariana Oncology is to discover and develop safe, effective, and highly targeted radiopharmaceuticals.

FogPharma’s key program aims to discover and develop direct-acting antagonists of β-catenin.  β-catenin is a key signaling hub in the Wnt pathway, which is activated by pathway mutations in nearly all colorectal cancers and a significant number of cancers of the liver, breast, prostate, endometrium and lung, among others.  In these cancers, the activations are all upstream of or in β-catenin; our antagonists are expected to block all Wnt-driven cancers, irrespective of their specific pathway mutation.

Warp Drive Bio is driving the reemergence of natural products in the era of genomics to create breakthrough treatments that make an important difference in the lives of patients. Built upon the belief that nature is the world’s most powerful medicinal chemist, Warp Drive Bio is deploying a battery of state-of-the-art technologies to access powerful drugs that are now hidden within microbes. Key to the Warp Drive Bio approach is the company’s proprietary “genomic search engine” and customized search queries that enable hidden natural products to be revealed on the basis of their distinctive genomic signature.

Ra Pharma™ is developing a new class of drugs with the diversity and specificity of antibodies, coupled with the oral bioavailability of small molecules. Our peptide-like molecules are highly-stable, synthetic products with chemical structures that offer intrinsic cell permeability. We are leveraging our technology to rapidly generate drug candidates to develop our own portfolio of products and partnerships focused on intracellular protein-protein interactions and other innovative approaches for addressing unmet medical needs.

AILERON Therapeutics is developing the first generation of peptide therapeutics directed at intra-cellular protein-protein interaction targets that are not addressable by current drug modalities. AILERON’s proprietary cell penetrating “Stapled Peptide” technology is being applied to generate breakthrough therapeutics for the treatment of cancer and other diseases. AILERON believes that “Stapled Peptides” have the potential to become a major new class of drugs for intracellular and extracellular targets across therapeutic areas. AILERON Therapeutics is an emerging biopharmaceutical company based in Cambridge, Mass. For more information please visit www.aileronrx.com

Midwest Biotech Inc, a privately held corporation, headquartered in suburban Indianapolis continues its excellence in serving the research needs of the pharmaceutical and biotechnological markets. Midwest Biotech Inc, long known for its outstanding quality and service stands alone when it comes to delivering precisely your desired product requests with the consistency and timeliness you have come to expect for over 20 years. For more information please visit www.midwestbiotech.com

Dover Adult Learning Center of Strafford County helps adults in the Strafford County area enhance their life-coping skills and improve their lives through basic education, job training, high school completion and enrichment classes. We help our students become more effective lifelong learners, family members, workers and citizens. For more information, please visit www.dalc-online.org